Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Babinchak

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of School Nursing : the Official Publication of the National Association of School Nurses|October 22, 2002
Causes of common illnesses: an overviewTimothy Babinchak
Diagnostic Microbiology and Infectious Disease|January 30, 2013
Tigecycline: an updateGary E Stein, Timothy Babinchak
Antimicrobial Agents and Chemotherapy|September 17, 2011
Clarification to the systematic review and meta-analysis involving tigecyclinePaul McGovern, Timothy Babinchak, Alvaro Quintana
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2009
Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trialsDavid Gardiner, Gary Dukart, Angel Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial dataTimothy Babinchak, Evelyn Ellis-Grosse, Nathalie Dartois, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2012
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenzaMark L Metersky, Robert G Masterton, Hartmut Lode, et al.
BMC Infectious Diseases|July 21, 2012
Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacinJulio A Ramirez, Angel C Cooper, Timothy Wiemken, et al.
BMC Infectious Diseases|November 14, 2012
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infectionsPeter Matthews, Marc Alpert, Galia Rahav, et al.
Diagnostic Microbiology and Infectious Disease|September 15, 2009
Exposure-response analyses of tigecycline tolerability in healthy subjectsJulie Passarell, Elizabeth Ludwig, Kathryn Liolios, et al.
BMC Infectious Diseases|October 21, 2005
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]María E Oliva, Arcot Rekha, Albert Yellin, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of School Nursing : the Official Publication of the National Association of School Nurses|October 22, 2002
Causes of common illnesses: an overviewTimothy Babinchak
Diagnostic Microbiology and Infectious Disease|January 30, 2013
Tigecycline: an updateGary E Stein, Timothy Babinchak
Antimicrobial Agents and Chemotherapy|September 17, 2011
Clarification to the systematic review and meta-analysis involving tigecyclinePaul McGovern, Timothy Babinchak, Alvaro Quintana
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2009
Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trialsDavid Gardiner, Gary Dukart, Angel Cooper, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial dataTimothy Babinchak, Evelyn Ellis-Grosse, Nathalie Dartois, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2012
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenzaMark L Metersky, Robert G Masterton, Hartmut Lode, et al.
BMC Infectious Diseases|July 21, 2012
Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacinJulio A Ramirez, Angel C Cooper, Timothy Wiemken, et al.
BMC Infectious Diseases|November 14, 2012
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infectionsPeter Matthews, Marc Alpert, Galia Rahav, et al.
Diagnostic Microbiology and Infectious Disease|September 15, 2009
Exposure-response analyses of tigecycline tolerability in healthy subjectsJulie Passarell, Elizabeth Ludwig, Kathryn Liolios, et al.
BMC Infectious Diseases|October 21, 2005
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]María E Oliva, Arcot Rekha, Albert Yellin, et al.
Pageof 2